Dyne Therapeutics

$17.10
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.06 (+0.35%) Today
$0.00 (0.00%) As of 6:00 PM EDT after-hours

Why Robinhood?

You can buy or sell DYN and other stocks, options, and ETFs commission-free!

About DYN

Dyne Therapeutics, Inc. engages in developing innovative life-transforming therapies for genetically driven muscle diseases. It develops a broad portfolio of therapeutics for muscle diseases, including lead programs in myotonic dystrophy type 1, Duchenne muscular dystrophy, and facioscapulohumeral muscular dystroph. Read More The company was founded by Jason P. Rhodes and Romesh R. Subramanian on December 1, 2017 and is headquartered in Waltham, MA. The listed name for DYN is Dyne Therapeutics, Inc. Common Stock.

Employees
Headquarters
Waltham, Massachusetts
Founded
2017
Market Cap
776.73M
Price-Earnings Ratio
Dividend Yield
Average Volume
285.00K
High Today
$18.33
Low Today
$16.06
Open Price
$17.03
Volume
303.72K
52 Week High
$27.11
52 Week Low
$15.60

Collections

You May Also Like